These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3221958)

  • 1. [Treatment of Wilson's disease with Zincteral].
    Kuczyńska-Zardzewiały A; Rodo M; Członkowska A
    Neurol Neurochir Pol; 1988; 22(3):211-5. PubMed ID: 3221958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of the treatment of Wilson's disease with zinc sulfate and d-penicillamine].
    Szleper M; Rodo M; Piłkowska E; Członkowska A
    Pol Tyg Lek; 1992 May 18-25; 47(20-21):456-8. PubMed ID: 1437767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of zinc sulfate in the treatment of Wilson's disease].
    Jonderko G; Pluta H; Wieczorek U
    Pol Tyg Lek; 1988 Apr; 43(14):459-60. PubMed ID: 3412983
    [No Abstract]   [Full Text] [Related]  

  • 4. Effective treatment of Wilson's disease with oral zinc sulphate: two case reports.
    Hoogenraad TU; Van den Hamer CJ; Van Hattum J
    Br Med J (Clin Res Ed); 1984 Aug; 289(6440):273-6. PubMed ID: 6430436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral zinc in Wilson disease--an alternative to D-penicillamine].
    Ramadori G; Keidl E; Hütteroth T; Dormeyer HH; Manns M; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1985 Jan; 23(1):25-9. PubMed ID: 4060799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral zinc sulphate treatment in Wilson's disease.
    Pasqualicchio M; Marrella M; Moretti U; Velo GP; Deganello A; Tomelleri G; Milanino R
    Acta Physiol Hung; 1990; 75 Suppl():233-4. PubMed ID: 2371874
    [No Abstract]   [Full Text] [Related]  

  • 7. Two and half years of oral zinc sulphate therapy in an adult patient with Wilson's disease.
    Pasqualicchio M; Milanino R; Marrella M; Moretti U; Tomelleri G; Velo GP
    Pharmacol Res; 1989; 21 Suppl 1():151-2. PubMed ID: 2633173
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-dose zinc therapy for maintenance treatment of Wilson's disease.
    Mayet IY
    Clin Pharm; 1990 Dec; 9(12):951-3. PubMed ID: 2292179
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful long term oral zinc in florid Wilson's disease: a case report.
    Kaur U; Bambery P; Bhushnurmath SR; Deodhar SD; Dilawari JB
    Trop Geogr Med; 1988 Apr; 40(2):161-5. PubMed ID: 3407008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral zinc sulphate as long-term treatment in Wilson's disease (hepatolenticular degeneration).
    Hoogenraad TU; Koevoet R; de Ruyter Korver EG
    Eur Neurol; 1979; 18(3):205-11. PubMed ID: 477692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Control of the therapeutic prevention of copper uptake in the liver in Wilson's disease following oral administration of 64Cu].
    Günther K; Siegemund R; Lössner J; Kühn HJ
    Radiobiol Radiother (Berl); 1988; 29(2):226-9. PubMed ID: 3399664
    [No Abstract]   [Full Text] [Related]  

  • 12. Zinc sulphate therapy for Wilson's disease after acute deterioration during treatment with low-dose D-penicillamine.
    Veen C; van den Hamer CJ; de Leeuw PW
    J Intern Med; 1991 Jun; 229(6):549-52. PubMed ID: 2045766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Wilson's disease with zinc sulphate. Experience in a series of 27 patients.
    Hoogenraad TU; Van Hattum J; Van den Hamer CJ
    J Neurol Sci; 1987 Feb; 77(2-3):137-46. PubMed ID: 3819764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
    Sinha S; Taly AB
    J Neurol Sci; 2008 Jan; 264(1-2):129-32. PubMed ID: 17765927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of oral ZnSO4 on urine copper and blood trace elements in 60 patients with Wilson's disease].
    Yang RM
    Zhonghua Yi Xue Za Zhi; 1986 Apr; 66(4):211-3, 254. PubMed ID: 3094875
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of Wilson's disease].
    Hoogenraad TU; van Hattum J
    Dtsch Med Wochenschr; 1987 Jun; 112(23):942-3. PubMed ID: 3582206
    [No Abstract]   [Full Text] [Related]  

  • 17. 3 years of continuous oral zinc therapy in 4 patients with Wilson's disease.
    Hoogenraad TU; Van den Hamer CJ
    Acta Neurol Scand; 1983 Jun; 67(6):356-64. PubMed ID: 6613522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic episode in a patient with Wilson's disease treated with zinc.
    Shimon I; Moses B; Sela BA; Dolev E
    Isr J Med Sci; 1993 Oct; 29(10):646-7. PubMed ID: 8244665
    [No Abstract]   [Full Text] [Related]  

  • 19. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
    Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
    Farinati F; Cardin R; D'inca R; Naccarato R; Sturniolo GC
    J Lab Clin Med; 2003 Jun; 141(6):372-7. PubMed ID: 12819634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.